150 related articles for article (PubMed ID: 11753902)
1. Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?
Neal DA; Alexander GJ
Liver Transpl; 2001 Dec; 7(12):1009-14. PubMed ID: 11753902
[TBL] [Abstract][Full Text] [Related]
2. Statins and cardiac allograft vasculopathy after heart transplantation.
Kobashigawa JA
Semin Vasc Med; 2004 Nov; 4(4):401-6. PubMed ID: 15861321
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hyperlipidemia in cardiac transplant recipients.
Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
[TBL] [Abstract][Full Text] [Related]
4. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
6. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
Butani L
Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
8. Statins: novel additions to the dermatologic arsenal?
Namazi MR
Exp Dermatol; 2004 Jun; 13(6):337-9. PubMed ID: 15186318
[TBL] [Abstract][Full Text] [Related]
9. Potential vascular benefits of statins.
Kinlay S
Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
[TBL] [Abstract][Full Text] [Related]
10. Statins as immunomodulatory agents.
Mach F
Circulation; 2004 Jun; 109(21 Suppl 1):II15-7. PubMed ID: 15173058
[TBL] [Abstract][Full Text] [Related]
11. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
[TBL] [Abstract][Full Text] [Related]
12. Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?
Steffens S; Mach F
Nat Clin Pract Nephrol; 2006 Jul; 2(7):378-87. PubMed ID: 16932466
[TBL] [Abstract][Full Text] [Related]
13. Statins: a treatment option for chronic heart failure?
von Haehling S; Okonko DO; Anker SD
Heart Fail Monit; 2004; 4(3):90-7. PubMed ID: 15772704
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory properties of statins.
Steffens S; Mach F
Semin Vasc Med; 2004 Nov; 4(4):417-22. PubMed ID: 15861323
[TBL] [Abstract][Full Text] [Related]
15. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
Ray KK; Cannon CP; Ganz P
Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Köenig W
J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
[TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.
Tamargo J; Caballero R; Gómez R; Núñez L; Vaquero M; Delpón E
Pharmacol Ther; 2007 Apr; 114(1):107-26. PubMed ID: 17287023
[TBL] [Abstract][Full Text] [Related]
19. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.
Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET
Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966
[TBL] [Abstract][Full Text] [Related]
20. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.
Arnaud C; Burger F; Steffens S; Veillard NR; Nguyen TH; Trono D; Mach F
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1231-6. PubMed ID: 15790934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
